Clonal analysis of Neisseria meningitidis serogroup B strains in South Africa, 2002 to 2006: Emergence of new clone ST-4240/6688

Journal of Clinical Microbiology

Volumn 50, Issue 11, 2012, Pages 3678-3686

  Moodley, Chivonne ^a,c   Du Plessis, Mignon ^a,b,c   Ndlangisa, Kedibone ^a,b,c   De Gouveia, Linda ^a,b,c   Klugman, Keith P ^b,c,d   Von Gottberg, Anne ^a,b,c  

^a NATIONAL INSTITUTE FOR COMMUNICABLE DISEASES   (South Africa)

^b UNIVERSITY OF THE WITWATERSRAND   (South Africa)

^c SOUTH AFRICAN MEDICAL RESEARCH COUNCIL   (South Africa)

^d EMORY UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FETA PROTEIN; OUTER MEMBRANE PROTEIN; PORIN A; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; ARTICLE; BACTERIAL STRAIN; BACTERIUM ISOLATE; CHILD; CLONE; FEMALE; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MENINGOCOCCOSIS; MICROBIAL DIVERSITY; MOLECULAR EPIDEMIOLOGY; MULTILOCUS SEQUENCE TYPING; NEISSERIA MENINGITIDIS; NONHUMAN; PRESCHOOL CHILD; PREVALENCE; PRIORITY JOURNAL; PULSED FIELD GEL ELECTROPHORESIS; SCHOOL CHILD; SOUTH AFRICA;

ADOLESCENT; ADULT; AGED; CHILD; CHILD, PRESCHOOL; CLUSTER ANALYSIS; DNA FINGERPRINTING; ELECTROPHORESIS, GEL, PULSED-FIELD; FEMALE; GENOTYPE; HUMANS; INCIDENCE; INFANT; MALE; MENINGOCOCCAL INFECTIONS; MIDDLE AGED; MOLECULAR EPIDEMIOLOGY; MULTILOCUS SEQUENCE TYPING; NEISSERIA MENINGITIDIS; SEROTYPING; SOUTH AFRICA; YOUNG ADULT;

EID: 84867550487     PISSN: 00951137     EISSN: 1098660X     Source Type: Journal    
DOI: 10.1128/JCM.01079-12     Document Type: Article

References (66)

1. Bjune G, et al. 1991. Effect of outer membrane vesicle vaccine against group B meningococcal disease in Norway. Lancet 338:1093-1096.
2. Brehony C, Jolley KA, Maiden MC. 2007. Multilocus sequence typing for global surveillance of meningococcal disease. FEMS Microbiol. Rev. 31: 15-26. (Pubitemid 46058816)
3. Bygraves JA, Maiden MC. 1992. Analysis of the clonal relationships between strains of Neisseria meningitidis by pulsed field gel electrophoresis. J. Gen. Microbiol. 138:523-531.
4. Caugant DA, et al. 1986. Multilocus genotypes determined by enzyme electrophoresis of Neisseria meningitidis isolated from patients with systemic disease and from healthy carriers. J. Gen. Microbiol. 132:641-652. (Pubitemid 16064046)
5. Caugant DA, et al. 1987. Intercontinental spread of Neisseria meningitidis clones of the ET-5 complex. Antonie Van Leeuwenhoek 53:389-394. (Pubitemid 18046555)
6. Caugant DA, Maiden MC. 2009. Meningococcal carriage and diseasepopulation biology and evolution. Vaccine 27(Suppl 2):B64-B70.
7. Chiou CS, et al. 2006. Molecular epidemiology and emergence of worldwide epidemic clones of Neisseria meningitidis in Taiwan.BMCInfect. Dis. 6:25. doi:10.1186/1471-2334-6-25.
8. Claus H, Elias J, Meinhardt C, Frosch M, Vogel U. 2007. Deletion of the meningococcal feta gene used for antigen sequence typing of invasive and commensal isolates from Germany: frequencies and mechanisms. J. Clin. Microbiol. 45:2960-2964. (Pubitemid 47417340)
9. Climent Y, et al. 2010. The genetic structure of Neisseria meningitidis populations in Cuba before and after the introduction of a serogroup BC vaccine. Infect. Genet. Evol. 10:546-554.
10. Coulson GB, et al. 2007. Meningococcal disease in South Africa, 1999-2002. Emerg. Infect. Dis. 13:273-281. (Pubitemid 46193172)
11. Cruz C, et al. 1990. Serotype-specific outbreak of group B meningococcal disease in Iquique, Chile. Epidemiol. Infect. 105:119-126.
12. de Filippis I, de Andrade CF, Silva L, Prevots DR, Vicente AC. 2007. PorA variable antigenic regions VR1, VR2, and VR3 of Neisseria meningitidis serogroups B and C isolated in Brazil from 1999 to 2004. Infect. Immun. 75:3683-3685. (Pubitemid 47040973)
13. Devoy AF, Dyet KH, Martin DR. 2005. Stability of PorA during a meningococcal disease epidemic. J. Clin. Microbiol. 43:832-837. (Pubitemid 40256042)
14. Diermayer M, et al. 1999. Epidemic serogroup B meningococcal disease in Oregon: the evolving epidemiology of the ET-5 strain. JAMA 281:1493-1497. (Pubitemid 29200932)
15. Diggle MA, Clarke SC. 2005. Increased genetic diversity of Neisseria meningitidis isolates after the introduction of meningococcal serogroup C polysaccharide conjugate vaccines. J. Clin. Microbiol. 43:4649-4653. (Pubitemid 41298257)
16. Reference deleted.
17. du Plessis M, et al. 16 May 2012. Population snapshot of invasive serogroup B meningococci in South Africa, 2005-2008. J. Clin. Microbiol. doi:10.1128/JCM.00401-12.
18. du Plessis M, von Gottberg A, Cohen C, de Gouveia L, Klugman KP.2008. Neisseria meningitidis intermediately resistant to penicillin and causing invasive disease in South Africa in 2001 to 2005. J. Clin. Microbiol. 46:3208-3214.
19. Dyet KH, Martin DR. 2006. Clonal analysis of the serogroup B meningococci causing New Zealand's epidemic. Epidemiol. Infect. 134:377-383. (Pubitemid 43280248)
20. Elias J, et al. 2006. Spatiotemporal analysis of invasive meningococcal disease, Germany. Emerg. Infect. Dis. 12:1689-1695. (Pubitemid 44674244)
21. Findlow J, et al. 2006. Comparison and correlation of neisseria meningitidis serogroup B immunologic assay results and human antibody responses following three doses of the Norwegian meningococcal outer membrane vesicle vaccine MenBvac. Infect. Immun. 74:4557-4565. (Pubitemid 44157242)
22. Finne J, Leinonen M, Makela PH. 1983. Antigenic similarities between brain components and bacteria causing meningitis. Implications for vaccine development and pathogenesis. Lancet ii:355-357. (Pubitemid 13028927)
23. Gautom RK. 1997. Rapid pulsed-field gel electrophoresis protocol for typing of Escherichia coli O157:H7 and other Gram-negative organisms in 1 day. J. Clin. Microbiol. 35:2977-2980. (Pubitemid 27452448)
24. Giuliani MM, et al. 2006. A universal vaccine for serogroup B meningococcus. Proc. Natl. Acad. Sci. U. S. A. 103:10834-10839. (Pubitemid 44148381)
25. Granoff DM. 2010. Review of meningococcal group B vaccines. Clin. Infect. Dis. 50(Suppl 2):S54-S65.
26. Harrison LH, et al. 2010. Population structure and capsular switching of invasive Neisseria meningitidis isolates in the pre-meningococcal conjugate vaccine era - United States, 2000-2005. J. Infect. Dis. 201:1208-1224.
27. Harrison LH, Trotter CL, Ramsay ME. 2009. Global epidemiology of meningococcal disease. Vaccine 27(Suppl 2):B51-B63.
28. Jiang HQ, et al. 2010. Broad vaccine coverage predicted for a bivalent recombinant factor H binding protein based vaccine to prevent serogroup B meningococcal disease. Vaccine 28:6086-6093.
29. Jolley KA, et al. 2000. Carried meningococci in the Czech Republic: a diverse recombining population. J. Clin. Microbiol. 38:4492-4498. (Pubitemid 32244539)
30. Law DK, et al. 2006. Invasive meningococcal disease in Quebec, Canada, due to an emerging clone of ST-269 serogroup B meningococci with serotype antigen 17 and serosubtype antigen P1.19 (B:17:P1.19). J. Clin. Microbiol. 44:2743-2749. (Pubitemid 44228566)
31. Lucidarme J, et al. 2009. Characterization of fHbp, nhba (gna2132), nadA, PorA, sequence type (ST), and genomic presence of IS1301 in group B meningococcal ST269 clonal complex isolates from England and Wales. J. Clin. Microbiol. 47:3577-3585.
32. Lucidarme J, et al. 2010. Characterization of fHbp, nhba (gna2132), nadA, PorA, and sequence type in group B meningococcal case isolates collected in England and Wales during January 2008 and potential coverage of an investigational group B meningococcal vaccine. Clin. Vaccine Immunol. 17:919-929.
33. Maiden MC. 1993. Population genetics of a transformable bacterium: the influence of horizontal genetic exchange on the biology of Neisseria meningitidis. FEMS Microbiol. Lett. 112:243-250. (Pubitemid 23280690)
34. Maiden MC, et al. 1998. Multilocus sequence typing: a portable approach to the identification of clones within populations of pathogenic microorganisms. Proc. Natl. Acad. Sci. U. S. A. 95:3140-3145. (Pubitemid 28135868)
35. Marsh JW, O'Leary MM, Shutt KA, Harrison LH. 2007. Deletion of fetA gene sequences in serogroup B and C Neisseria meningitidis isolates. J. Clin. Microbiol. 45:1333-1335. (Pubitemid 46626510)
36. McEllistrem MC, et al. 2004. Correlating epidemiologic trends with the genotypes causing meningococcal disease, Maryland. Emerg. Infect. Dis. 10:451-456. (Pubitemid 38314471)
37. Mothibeli KM, et al. 2011. Distribution of factor H binding protein beyond serogroup B: variation among five serogroups of invasive Neisseria meningitidis in South Africa. Vaccine 29:2187-2192.
38. Nokleby H, et al. 2007. Safety review: two outer membrane vesicle (OMV) vaccines against systemic Neisseria meningitidis serogroup B disease. Vaccine 25:3080-3084. (Pubitemid 46505045)
39. Orren A, et al. 1994. Characterization of strains of Neisseria meningitidis recovered from complement-sufficient and complement-deficient patients in the Western Cape Province, South Africa. J. Clin. Microbiol. 32:2185-2191. (Pubitemid 24258462)
40. Orskov F, Orskov I. 1983. Summary of a workshop on the clonal concept in the epidemiology, taxonomy, and evolution of the Enterobacteriaceae and other bacteria. J. Infect. Dis. 148:346-357.
41. Poland GA. 2010. Prevention of meningococcal disease: current use of polysaccharide and conjugate vaccines. Clin. Infect. Dis. 50(Suppl 2):S45-S53.
42. Poolman JT, et al. 1986. Meningococcal serotypes and serogroup B disease in north-west Europe. Lancet ii:555-558.
43. Popovic T, et al. 2001. Evaluation of pulsed-field gel electrophoresis in epidemiological investigations of meningococcal disease outbreaks caused by Neisseria meningitidis serogroup C. J. Clin. Microbiol. 39:75-85. (Pubitemid 32059572)
44. Racloz VN, Luiz SJ. 2010. The elusive meningococcal meningitis serogroup: a systematic review of serogroup B epidemiology. BMC Infect. Dis. 10:175.
45. Rosenstein N, Perkins B, Stephens DS, Popovic T, Hughes JM. 2001. Meningococcal disease. N. Engl. J. Med. 344:1378-1388.
46. Rosenstein NE, et al. 1999. The changing epidemiology of meningococcal disease in the United States, 1992-1996. J. Infect. Dis. 180:1894-1901.
47. Sacchi CT, et al. 1998. Proposed standardization of Neisseria meningitidis PorA variable-region typing nomenclature. Clin. Diagn. Lab. Immunol. 5:845-855. (Pubitemid 28519264)
48. Sacchi CT, et al. 2001. Serosubtypes and PorA types of Neisseria meningitidis serogroup B isolated in Brazil during 1997-1998: overview and implications for vaccine development. J. Clin. Microbiol. 39:2897-2903. (Pubitemid 32744008)
49. Sacchi CT, et al. 1992. Ongoing group B Neisseria meningitidis epidemic in Sao Paulo, Brazil, due to increased prevalence of a single clone of the ET-5 complex. J. Clin. Microbiol. 30:1734-1738.
50. Scholten RJ, et al. 1993. Meningococcal disease in The Netherlands, 1958-1990: a steady increase in the incidence since 1982 partially caused by new serotypes and subtypes of Neisseria meningitidis. Clin. Infect. Dis. 16:237-246. (Pubitemid 23047423)
51. Sosa J, et al. 2001. Typing and susceptibility to penicillin of Neisseria meningitidis isolated from patients in Cuba (1993-1999). Mem. Inst. Oswaldo Cruz 96:523-525. (Pubitemid 33639644)
52. Stein-Zamir C, et al. 2008. Invasive meningococcal disease in children in Jerusalem. Epidemiol. Infect. 136:782-789. (Pubitemid 351524013)
53. Takahashi H, et al. 2004. Characterization of Neisseria meningitidis isolates collected from 1974 to 2003 in Japan by multilocus sequence typing. J. Med. Microbiol. 53:657-662. (Pubitemid 38932365)
54. Tan LK, Carlone GM, Borrow R. 2010. Advances in the development of vaccines against Neisseria meningitidis. N. Engl. J. Med. 362:1511-1520.
55. Tenover FC, et al. 1995. Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. J. Clin. Microbiol. 33:2233-2239.
56. Tondella ML, et al. 2000. Distribution of Neisseria meningitidis serogroup B serosubtypes and serotypes circulating in the United States. The Active Bacterial Core Surveillance Team. J. Clin. Microbiol. 38:3323-3328.
57. Trotter CL, et al. 2007. A surveillance network for meningococcal disease in Europe. FEMS Microbiol. Rev. 31:27-36. (Pubitemid 46058817)
58. Urwin R, et al. 2004. Distribution of surface protein variants among hyperinvasive meningococci: implications for vaccine design. Infect. Immun. 72:5955-5962.
59. van der Ende A, Hopman CT, Dankert J. 2000. Multiple mechanisms of phase variation of PorA in Neisseria meningitidis. Infect. Immun. 68: 6685-6690.
60. van der Ende A, et al. 2003. Outbreak of meningococcal disease caused by PorA-deficient meningococci. J. Infect. Dis. 187:869-871.
61. Vicente D, Esnal O, Lopez de Goicoechea MJ, Cisterna R, Perez-Trallero E. 2009. Influence of two vaccination campaigns on genetic diversity of invasive Neisseria meningitidis isolates in northern Spain (1997-2008). PLoS One 4:e8501. doi:10.1371/journal.pone.0008501.
62. Vicente D, et al. 2005. Prevalence of genosubtypes (PorA types) of serogroup B invasive meningococcus in the north of Spain from 2000 to 2003. J. Med. Microbiol. 54:381-384.
63. von Gottberg A, et al. 2008. Emergence of endemic serogroup W135 meningococcal disease associated with a high mortality rate in South Africa. Clin. Infect. Dis. 46:377-386.
64. Wasas AD, Huebner RE, Klugman KP. 1999. Use of Dorset egg medium for maintenance and transport of Neisseria meningitidis and Haemophilus influenzae type b. J. Clin. Microbiol. 37:2045-2046. (Pubitemid 29235275)
65. Wedege E, et al. 2007. Functional and specific antibody responses in adult volunteers in New Zealand who were given one of two different meningococcal serogroup B outer membrane vesicle vaccines. Clin. Vaccine Immunol. 14:830-838.
66. Yazdankhah SP, et al. 2004. Distribution of serogroups and genotypes among disease-associated and carried isolates of Neisseria meningitidis from the Czech Republic, Greece, and Norway. J. Clin. Microbiol. 42: 5146-5153. (Pubitemid 39506223)